NEWS
Mar 2020: 3 more hospitals use DeltaScan in routine care
In March 2020 a third lot of hospital departments enrolled in the intervention phase of CLEO (Clinical Evaluation Of DeltaScan)! In this phase they switch completely to using the world’s first objective device (DeltaScan), for detection and monitoring of all their patients at risk of delirium.
In the next months of 2020 all departments will switch the intervention phase.
For more information, click on picture above.
Feb 2020: 2 more hospitals use DeltaScan in routine care
In February 2020 a second lot of hospital departments enrolled in the intervention phase of CLEO (Clinical Evaluation Of DeltaScan)! In this phase they switch completely to using the world’s first objective device (DeltaScan), for detection and monitoring of all their patients at risk of delirium.
In the next months of 2020 all departments will switch the intervention phase.
For more information, click on picture above.
Prolira @ German congress “Thorax-, Heart & Vascular Surgery”on 29 Feb – 3 Mar 2020
From 29 Feb – 3 Mar 2020, Prolira and Ecumed (G) together exhibited @ the annual congress of the Deutsche Gesellschaft für Thorax-, Herz- und Gefässchirurgie in Wiesbaden, Germany. For more information, click on the picture.
Prolira @ congress “Symposium Intensive Medicine + Intensive Care”on 24-26 Feb 2020
on 24-26 Feb 2020, Prolira and Ecumed (G) met with many German ICU phycisians and nurses @ at the “Symposium Intensivmedizin +Intensivpflege” in Bremen, Germany. For more information, click on the picture.
Prolira @ ISICEM in Brussels on 24-27 Mar 2020
on 24-27 Mar 2020, Prolira will exhibit @ ISICEM Intensive Care Congress in Brussels, Belgium.
For more information, please click on the picture.
Prolira @ congress “Geriatric days” on 11-12 Feb 2020
on 11-12 Feb 2020, Prolira met with many geriatric care professionals @ at the “Geriatric days” in den Bosch, the Netherlands. For more information, click on the picture.
More hospital departments use DeltaScan in routine care
In February 2020 a second lot of hospital departments enrolled in the intervention phase of CLEO (Clinical Evaluation Of DeltaScan)! In this phase they switch completely to using the world’s first objective device (DeltaScan), for detection and monitoring of all their patients at risk of delirium.
In the next months of 2020 all departments will switch the intervention phase.
For more information, click on picture above.
Prolira @ congress “preparing for admission is better than cure”
on 24 Jan 2020, Prolira met with many (cardiac) surgery care professionals @ at the “preparing for admission is better than cure!” congress. For more information, click on Prolira’s ‘ad’ above.
2020 starts well: first hospitals use DeltaScan in routine care
We hope that for you all, the year 2020 had a start as good as ours! In January 2020 the first pair of hospital departments enrolled in the exciting ‘intervention phase’ of CLEO (Clinical Evaluation Of DeltaScan)! In this phase they switch completely to using the world’s first objective device (DeltaScan), for detection and monitoring of all their patients at risk of delirium. In the next months of 2020 all departments will switch the intervention phase.
For more information, click on picture above.
Superuser day @ UMC Utrecht & Prolira for CLEO
Staff from all Dutch hospitals that participate in CLEO (Clinical Evaluation of DeltaScan) gathered on 5 November 2019 @ UMC Utrecht, to practise using DeltaScan, in preparation of the start of the intervention phase of CLEO, in which DeltaScan will be used to daily detect and monitor delirium in their patients.
For more information, click on the picture.
Prolira B.V.
Padualaan 8
3584 CH Utrecht
The Netherlands
tel: +31 (0)6 2297 8972
info@prolira.com